XRHealth acquires Swing Therapeutics to expand its AI-powered digital health platform beyond XR into mobile apps, wearables, and FDA-authorized digital therapeutics for chronic pain and fibromyalgia, creating a comprehensive, reimbursable care platform.
The financial terms of the transactions were not disclosed. Swing has raised a total of $30 million in funding to date, including $11 million raised last year. It was backed by investors, including JAZZ Venture Partners with participation by Alumni Ventures, AME Cloud Ventures, Asahi Kasei Corporate Ventures, Gaingels, Kicker Ventures, Mana Ventures, and Metrodora Ventures,
XR Health has raised $50 million in funding to date.
With the acquisition of Swing Therapeutics, XRHealth can now serve patients across physical, cognitive, and behavioral health with an unmatched depth of clinical evidence and breadth of therapeutic modalities.
Founded in 2019, Swing Therapeutics provides patients with high-quality treatment through Swing Care, a comprehensive virtual clinic for chronic pain treatment, with strong clinical outcomes. At the one-year mark, 88.0% of patients reported improvement in overall wellbeing (PGIC), with over half (50.2%) stating they felt “much improved” or better.
“When we founded Swing, we believed that the future of chronic pain care had to look fundamentally different: more accessible, more personalized, and grounded in evidence,” says Mike Rosenbluth, Founder and CEO of Swing Therapeutics, Inc. “Joining XRHealth means we can deliver on that vision at an expanded scale, with clinicians and technology working together through a single platform where patients can access every dimension of their care.”
“The future of therapeutic care is technology. Not as a supplement to medicine, but as the medicine itself—delivered through AI, monitored by licensed clinicians, reimbursed by insurance, and continuously improved by outcomes data,” says Eran Orr, CEO of XRHealth. “The healthcare system has a supply and demand problem: too few clinicians, too many patients, and costs that are out of reach for most. Technology is how we solve that. XRHealth and Swing Therapeutics together represent the most comprehensive approach to this challenge ever assembled—spanning devices, apps, digital therapeutics, clinical care, and peer support, all in one platform. We are building the infrastructure for the next era of medicine.”